Evidence map›Paper›PMID 40709790›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2025

Trends in the Use of Vaping Products and Other Smoking Cessation Methods Among Adults Who Attempt to Stop Smoking: Findings From the International Tobacco Control Four-Country Smoking and Vaping Surveys (2016-2020).

Kimberly D'Mello, Pete Driezen, Katherine A East, Geoffrey T Fong, David Hammond

Abstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Intentions to Use FDA-Authorized E-Cigarettes Among Adults Who Smoke Cigarettes in the United States.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kimberly D'MelloSchool of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.ORCID 0000-0003-3498-0038
Pete DriezenSchool of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.ORCID 0000-0003-2320-0999
Katherine A EastDepartment of Primary Care and Public Health, Brighton and Sussex Medical School, University of Brighton and University of Sussex, Brighton, United Kingdom.ORCID 0000-0001-9083-2131
Geoffrey T FongSchool of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.
David HammondSchool of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.ORCID 0000-0001-8197-6010

Funding

Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FONG, GEOFFREY T · 2016 to 2025
$25.3M
CIHR FDN-148477National Health and Medical Research Council of Australia APP1106451NCI NIH HHS P01 CA200512
6 · The paper itself

Abstract

introductionE-cigarettes are an increasingly popular method of smoking cessation assistance; however, there is little research on whether this has affected the number of smokers who quit using "any" evidence-based cessation aid. This study examined trends in the use of cessation aids, including e-cigarettes and other evidence-based methods. AIMS AND

methodsData were cross-sectional surveys in 2016, 2018, and 2020 from the International Tobacco Control Four Country Smoking and Vaping Survey conducted in Canada, United States (US), England, and Australia. Respondents were adults (≥18) recruited by commercial panel firms who currently smoked, and/or quit smoking in the past 12 months. Respondents were asked about use of e-cigarettes, nicotine replacement therapies, prescription medications, quitlines, and counseling services during their last quit attempt (LQA). Generalized estimating equation regression models that were analyzed separately by country examined use of cessation assistance among 14 536 observations (Canada = 4880; US = 2917; England = 4846; and Australia = 1898).

resultsE-cigarettes (29.9%) and nicotine replacement therapy (29.8%) were popular methods of cessation assistance at LQA. Using e-cigarettes at LQA increased in Australia (2016 = 11.1%; 2020 = 25.1%; p=.002) and England (2016 = 37.1%; 2018 = 46.7%; p=.002), with no significant change in Canada or the US. Across all countries, there was little change over time in the overall use of evidence-based cessation assistance. Nearly half of respondents used some form of cessation assistance excluding e-cigarettes. Approximately two-thirds used "any" form of evidence-based cessation including e-cigarettes at LQA, which decreased in Canada (2016 = 64.0%, 2020 = 58.9%; p=.010).

conclusionsWhile e-cigarettes are a popular cessation aid, use of other evidence-based cessation assistance has remained comparatively stable among adults that tried to quit smoking. IMPLICATIONS: The findings indicated that e-cigarettes are a popular cessation method among adults trying to quit smoking. Despite differences in e-cigarette use and regulatory environments in the four countries, rates of evidence-based cessation assistance were similar across countries and over time. E-cigarettes can be an effective method for stopping smoking; however, the current study suggests few, if any, changes in the proportion of adults who smoke using any evidence-based form of cessation assistance, despite changes in the use of e-cigarettes as a quit aid.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationTobacco Use Cessation DevicesVapingAdolescentAdultAustraliaCanadaCross-Sectional StudiesEnglandFemaleHumansMaleMiddle AgedSurveys and QuestionnairesTobacco Control

Identifiers

PMID40709790
PMCPMC12641179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.